Skip to main content

A sustainable house design to improve child health in rural Africa: a cluster-randomized controlled trial.

Nature medicine2026-04-22PubMed
Total: 88.5Innovation: 9Impact: 0Rigor: 0Citation: 0

Summary

In a cluster-randomized trial of 110 “Star Homes” versus 513 traditional houses over 3 years, children living in the redesigned, insect-proof, smoke-free homes experienced 44% less malaria, 30% less diarrhea, and 18% fewer acute respiratory infections. Children under five were taller for age, highlighting broad health benefits from an integrated built-environment intervention.

Key Findings

  • Children in Star Homes had 44% lower malaria incidence (IRR 0.56, 95% CI 0.43–0.72), 30% less diarrhea (IRR 0.70, 95% CI 0.53–0.91), and 18% fewer ARIs (IRR 0.82, 95% CI 0.73–0.93).
  • The intervention combined insect-proofing, reduced indoor smoke exposure, improved cooling, and reliable water/sanitation in a two-story design.
  • Children under 5 years living in Star Homes were taller-for-age compared with those in traditional homes.
  • Cluster randomization allocated 110 Star Homes versus 513 traditional houses, with outcomes measured over 3 years.

Clinical Implications

Integrating insect-proofing, clean indoor air (smoke-free cooking), and reliable water/sanitation into housing can reduce ARI incidence at the population level. Public health programs and donors should consider built-environment upgrades as core components of child respiratory health strategies.

Why It Matters

This study demonstrates that structural housing innovations can substantially reduce ARI burden alongside other major child killers in real-world rural African settings, providing a scalable preventive strategy.

Limitations

  • Open-label nature and bundled intervention limit attribution to specific components
  • Generalizability beyond study regions requires replication and cost-effectiveness analyses

Future Directions

Replicate across ecological zones, quantify indoor air quality and exposure pathways, and conduct cost-effectiveness and implementation studies to guide national scale-up.

Study Information

Study Type
RCT
Research Domain
Prevention
Evidence Level
I - Cluster-randomized controlled trial with prospective follow-up.
Study Design
OTHER